Change of COO at Idorsia

Swiss biotech Idorsia (SIX: IDIA) today revealed that Simon Jose will leave his position as chief commercial officer and member of the Idorsia executive committee to pursue other opportunities.

As a result, Idorsia says that Otto Schwarz has agreed to advise the management team on commercial operations effective July 1, 2023.

Mr Schwartz is a highly accomplished industry executive with more than 35 years of experience. He has launched multiple major specialty products on a global basis. Most recently, he served as executive vice president, chief operating officer and a member of the Actelion executive committee, until the acquisition of Actelion by Johnson & Johnson (NYSE: JNJ), which also resulted in the spin-out of Idorsia in 2017.